NCT04501185

Brief Summary

In the present study, two types of cementless femoral stem- UTS Stem and UTF-reduced Stem- were utilized in total hip arthroplasty. Due to the design for proximal femur fixation, both femoral stems could prevent stress shielding around the implant, further preventing osteolysis. The difference between both femoral stems is the length, in which UTS Stem is 20% shorter than UTF-reduced Stem. The clinical outcomes of both femoral stems will be compared. Both femoral stems are expected to have equally good radiologic outcome and clinical performance.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 6, 2020

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

October 10, 2023

Status Verified

September 1, 2023

Enrollment Period

5.9 years

First QC Date

August 3, 2020

Last Update Submit

October 5, 2023

Conditions

Keywords

total hip arthroplastytotal hip replacementfemoral stem

Outcome Measures

Primary Outcomes (5)

  • Success rate

    Failure is defined as removal or revision of any components as a result of mechanical failure or complications. Sucess is defined as implants that are sucessfully implanted without any failure for the duration of 1 year. The success rate will be represented as a percentage (%).

    Duration of 1 year

  • Numerical Rating Scale

    Numerical Rating Scale is a patient-reported outcome measure. The scale ranges from 0 to 10. A score of 0 represents no pain, while a score of 10 represents extreme pain.

    Change from baseline at 1 year

  • Harris Hip Score

    Harris Hip Score includes 4 sections that evaluate pain, function, deformity, and range of motion. Total scores is from 0 to 100, higher scores represent a better outcome.

    Change from baseline at 1 year

  • Medical Outcome Study Short Form-36

    SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients. It consists of two sections, physical component summary and mental component summary, with 36 items in total.

    Change from baseline at 1 year

  • DEXA scanning

    DEXA scanning is used to monitor and quantify bone mineral density, which helps to understand if the implant has an effect on the change of bone mineral density.

    Change from baseline at 1 year

Secondary Outcomes (3)

  • Radiolucent line

    Change from baseline at 1 year

  • Valgus/Varus alignment

    Change from baseline at 1 year

  • Morphology of the proximal femur

    at baseline

Study Arms (2)

UTS Stem

The subjects who received UTS Stem in total hip arthroplasty.

Device: total hip arthroplasty

UTF-reduced Stem

The subjects who received UTF-reduced Stem in total hip arthroplasty.

Device: total hip arthroplasty

Interventions

The indication for total hip arthroplasty is mainly osteoarthritis.

UTF-reduced StemUTS Stem

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who receive total hip arthroplasty with either a UTS femoral stem or a UTF-reduced femoral stem after June, 2020 at Chang Gung Memorial Hospital, Linkou

You may qualify if:

  • Patients who receive total hip arthroplasty with either a UTS femoral stem or a UTF-reduced femoral stem after June, 2020
  • Patients who have not received total hip arthroplasty in the past

You may not qualify if:

  • Patients who are unable or unwilling to return for follow-up
  • Patients who suffer from mental disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joint Reconstruction Division at Chang Gung Memorial Hospital, Linkou

Taoyuan, 333, Taiwan

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Hip

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Pang-Hsin Hsieh, MD

    Chang Gung Memorial Hospital

    STUDY DIRECTOR

Central Study Contacts

Pang-Hsin Hsieh, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2020

First Posted

August 6, 2020

Study Start

June 1, 2020

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

October 10, 2023

Record last verified: 2023-09

Locations